Page last updated: 2024-11-05

trifluoperazine and Inappropriate ADH Syndrome

trifluoperazine has been researched along with Inappropriate ADH Syndrome in 2 studies

Inappropriate ADH Syndrome: A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamburger, S1
Langley, H1
Bowers, G1
Kennedy, MJ1
Shelley, RK1
Daly, PA1

Other Studies

2 other studies available for trifluoperazine and Inappropriate ADH Syndrome

ArticleYear
The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline or trifluoperazine administration.
    The Journal of the Kansas Medical Society, 1980, Volume: 81, Issue:10

    Topics: Amitriptyline; Female; Humans; Inappropriate ADH Syndrome; Middle Aged; Trifluoperazine

1980
Potentiation of small cell lung cancer-related SIADH by trifluoperazine.
    European journal of respiratory diseases, 1987, Volume: 71, Issue:5

    Topics: Carcinoma, Small Cell; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middl

1987